Journal of Peking University(Health Sciences) ›› 2015, Vol. 47 ›› Issue (4): 597-600. doi: 10.3969/j.issn.1671-167X.2015.04.009
• Articles • Previous Articles Next Articles
LIU Lei, HOU Xiao-fei△, MA Lu-lin, ZHAO Lei, ZHANG Hong-xian
CLC Number:
[1] | Yi-chang HAO,Ye YAN,Fan ZHANG,Min QIU,Lang ZHOU,Ke LIU,Jian LU,Chun-lei XIAO,Yi HUANG,Cheng LIU,Lu-lin MA. Surgical strategy selection and experience summary of prostate cancer with positive single needle biopsy [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 625-631. |
[2] | Yi LIU,Zhi-jian LIU,Qi SHEN,Jing-yun WU,Yu FAN,De-run LI,Wei YU,Zhi-song HE. A clinical analysis of 14 cases of prostatic stromal tumor of uncertain malignant potential [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 621-624. |
[3] | Ye YAN,Hai-zhui XIA,Xu-sheng LI,Wei HE,Xue-hua ZHU,Zhi-ying ZHANG,Chun-lei XIAO,Yu-qing LIU,Hua HUANG,Liang-hua HE,Jian LU. Application of U-shaped convolutional neural network in auto segmentation and reconstruction of 3D prostate model in laparoscopic prostatectomy navigation [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 596-601. |
[4] | ZHANG Fan, XIAO Chun-lei, ZHANG Shu-dong, HUANG Yi, MA Lu-lin. Relationship between recovery of urinary continence after laparoscopic radical prostatectomy and prostatic volume and intravesical prostatic protursion length [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 621-625. |
[5] | BI Yong-xiang, XIAO Min-hui, ZHANG Ning-nan, LI Xiao-yun, MAO Xiao-peng, ZHANG Ke, ZHANG Zhuo-rui, ZHAO Liang-yun. Construction and improvement of animal models with different positional osseous metastasis of prostate cancer in vivo [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 590-596. |
[6] | LIU Zhuo, LUO Cheng, HU Shuai, FAN Yu, LIU Zhen-hua, YANG Xin-yu, SHEN Qi, LIU Li-bo, HAN Wen-ke, ZHOU Li-qun, YU Wei, HE Qun, ZHANG Qian, JIN Jie. Diagnosis and treatment of T1a-T1b prostate cancer [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 812-816. |
[7] | WANG Gong-wei, SHEN Dan-hua, ZHANG Wei-Yu, XU Ke-xin, XU Tao, HU Hao. Trends in Gleason scores of Chinese prostate carcinoma from 1995 to 2014 [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 801-805. |
[8] | LIU Zhuo, MA Lu-lin, ZHANG Shu-dong, LU Min, TIAN Yu, HE Qun, JIN Jie. Basal cell carcinoma of prostate: a report of three cases [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 720-724. |
[9] | ZUO Qiang, ZHANG Fan, HUANG Yi, MA Lu-lin, LU Min, LU Jian. Clinically predictive factors of Gleason score upgrading in patients after radical prostatectomy [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 603-606. |
[10] | HU Feng-zhan, YUAN Wan-qiong, WANG Xiao-lin, QIN Cai-peng, SHENG Zheng-zuo, DU Yi-qing, YIN Hua-qi, XU Tao. Knockdown of CMTM3 promotes migration and invasion of PC3 cell in vitro [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 594-597. |
[11] | ZHANG Feng-Bo, DU Yuan, SHAO Qiang, TIAN Ye. Treatment of local low/intermediate risk prostate cancer with low dose rate brachytherapy: a report of 133 cases at a single center [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 611-614. |
[12] | YANG Kai-Wei, YU Wei, SONG Yi, HUANG Li-Hua, HAN Wen-Ke, HE Zhi-Song, JIN Jie, ZHOU Li-Qun. Predictor analysis of PSA response of docetaxel combined with prednisone in the treatment of metastatic castration resistant prostate cancer [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 592-596. |
[13] | FAN Yu, Liu-Zhuo, Zhang-Lian, Li-De-Run, He-Qun, Yang-Xin-Yu, Shen-Qi, Hu-Shuai, Liu-Li-Bo, Shan-Gang-Zhi, Li-Shu-Qing, Meng-Yi-Sen, Wang-Yu, Yu-Wei, Zhang-Qian, He-Zhi-Song, Zhou-Li-Qun, Jin-Jie. A head-to-head comparison of contemporary indolent prostate cancer screen protocols in Chinese [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 586-591. |
[14] | YUAN Ye-Qing, ZHANG Yi-Xiang, LIU Zhen-Hua, QIN Cai-Peng, SHENG Zheng-Zuo, XU Tao, WANG Xiao-Feng. Expression and significance of CMTM5 and epidermal growth factor receptor in prostate cancer [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 571-576. |
[15] | MA Hong, ZHU Gang, WAN Ben, WU Peng-Jie, WANG Jian-Ye. Use of abiraterone acetate in the treatment of patients with metastatic castration resistant prostate cancer and no prior chemotherapy: 3 case reports and literature review [J]. Journal of Peking University(Health Sciences), 2014, 46(4): 653-656. |
|